A phase I study of PXL 770 in healthy volunteers
Phase of Trial: Phase I
Latest Information Update: 03 Apr 2017
At a glance
- Drugs PXL 770 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions; Proof of concept
- Sponsors Poxel
- 03 Apr 2017 According to a Poxel media release, company plans to initiate the multiple ascending dose portion of the Phase 1 study during the second half of 2017.
- 27 Jan 2017 According to a Poxel media release, the company anticipates to continue the study during the second half of this year.
- 27 Sep 2016 According to a Poxel media release, the second part of the phase 1b study is expected in 2017.